First Nebraska Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.01M | Sell |
69,352
-123
| -0.2% | -$11.8K | 0.56% | 41 |
|
|
2025
Q4 | $6.67M | Buy |
69,475
+178
| +0.3% | +$17.3K | 0.61% | 38 |
|
|
2025
Q3 | $6.6M | Buy |
69,297
+1,317
| +2% | +$121K | 0.6% | 39 |
|
|
2025
Q2 | $5.93M | Sell |
67,980
-424
| -0.6% | -$36K | 0.57% | 41 |
|
|
2025
Q1 | $6.15M | Buy |
68,404
+9,165
| +15% | +$820K | 0.61% | 39 |
|
|
2024
Q4 | $4.73M | Sell |
59,239
-19,078
| -24% | -$1.65M | 0.46% | 51 |
|
|
2024
Q3 | $7.05M | Buy |
78,317
+2,055
| +3% | +$173K | 0.69% | 37 |
|
|
2024
Q2 | $6M | Buy |
76,262
+188
| +0.2% | +$15.4K | 0.62% | 41 |
|
|
2024
Q1 | $6.63M | Buy |
76,074
+3,360
| +5% | +$287K | 0.68% | 39 |
|
|
2023
Q4 | $5.99M | Sell |
72,714
-1,180
| -2% | -$89.9K | 0.69% | 38 |
|
|
2023
Q3 | $5.79M | Buy |
73,894
+25
| +0% | +$2.09K | 0.72% | 34 |
|
|
2023
Q2 | $6.51M | Sell |
73,869
-45
| -0.1% | -$3.87K | 0.78% | 32 |
|
|
2023
Q1 | $5.96M | Buy |
73,914
+3,655
| +5% | +$298K | 0.75% | 31 |
|
|
2022
Q4 | $5.46M | Sell |
70,259
-1,192
| -2% | -$96.6K | 0.71% | 38 |
|
|
2022
Q3 | $5.77M | Buy |
71,451
+3,048
| +4% | +$274K | 0.83% | 30 |
|
|
2022
Q2 | $6.14M | Sell |
68,403
-125
| -0.2% | -$12.7K | 0.81% | 30 |
|
|
2022
Q1 | $7.6M | Buy |
68,528
+1,250
| +2% | +$132K | 0.9% | 28 |
|
|
2021
Q4 | $6.96M | Buy |
67,278
+2,987
| +5% | +$346K | 0.84% | 30 |
|
|
2021
Q3 | $8.06M | Sell |
64,291
-118
| -0.2% | -$15.3K | 1.05% | 22 |
|
|
2021
Q2 | $8M | Sell |
64,409
-475
| -0.7% | -$59.6K | 1.04% | 23 |
|
|
2021
Q1 | $7.66M | Buy |
64,884
+295
| +0.5% | +$34.6K | 1.03% | 23 |
|
|
2020
Q4 | $7.57M | Sell |
64,589
-541
| -0.8% | -$59.6K | 1.09% | 21 |
|
|
2020
Q3 | $6.77M | Buy |
65,130
+322
| +0.5% | +$32.3K | 1.16% | 22 |
|
|
2020
Q2 | $5.94M | Buy |
64,808
+543
| +0.8% | +$52.1K | 1.1% | 22 |
|
|
2020
Q1 | $5.8M | Buy |
64,265
+6,300
| +11% | +$670K | 1.28% | 21 |
|
|
2019
Q4 | $6.58M | Sell |
57,965
-16
| -0% | -$1.76K | 1.07% | 23 |
|
|
2019
Q3 | $6.3M | Sell |
57,981
-288
| -0.5% | -$30K | 1.05% | 23 |
|
|
2019
Q2 | $5.67M | Buy |
58,269
+900
| +2% | +$82.2K | 0.99% | 24 |
|
|
2019
Q1 | $5.23M | Sell |
57,369
-163
| -0.3% | -$14.6K | 0.94% | 26 |
|
|
2018
Q4 | $5.23M | Sell |
57,532
-435
| -0.8% | -$40.6K | 1.06% | 23 |
|
|
2018
Q3 | $5.7M | Sell |
57,967
-525
| -0.9% | -$48.5K | 0.97% | 24 |
|
|
2018
Q2 | $5.01M | Buy |
58,492
+3,300
| +6% | +$276K | 1.07% | 27 |
|
|
2018
Q1 | $4.43M | Buy |
55,192
+19,410
| +54% | +$1.6M | 0.88% | 27 |
|
|
2017
Q4 | $2.89M | Buy |
35,782
+4,251
| +13% | +$340K | 0.59% | 44 |
|
|
2017
Q3 | $2.45M | Sell |
31,531
-250
| -0.8% | -$20.8K | 0.54% | 46 |
|
|
2017
Q2 | $2.82M | Sell |
31,781
-559
| -2% | -$47.1K | 0.63% | 41 |
|
|
2017
Q1 | $2.61M | Buy |
32,340
+25
| +0.1% | +$1.95K | 0.58% | 44 |
|
|
2016
Q4 | $2.3M | Buy |
32,315
+7,797
| +32% | +$613K | 0.55% | 43 |
|
|
2016
Q3 | $2.12M | Sell |
24,518
-125
| -0.5% | -$10.9K | 0.55% | 44 |
|
|
2016
Q2 | $2.14M | Buy |
24,643
+400
| +2% | +$32.3K | 0.56% | 42 |
|
|
2016
Q1 | $1.82M | Sell |
24,243
-112
| -0.5% | -$8.44K | 0.5% | 44 |
|
|
2015
Q4 | $1.87M | Sell |
24,355
-95
| -0.4% | -$7.15K | 0.56% | 41 |
|
|
2015
Q3 | $1.64M | Sell |
24,450
-25,492
| -51% | -$1.88M | 0.52% | 42 |
|
|
2015
Q2 | $3.7M | Sell |
49,942
-1,225
| -2% | -$93.6K | 1.13% | 29 |
|
|
2015
Q1 | $3.99M | Hold |
51,167
| – | – | 1.18% | 29 |
|
|
2014
Q4 | $3.69M | Sell |
51,167
-3,848
| -7% | -$267K | 1.07% | 28 |
|
|
2014
Q3 | $3.41M | Sell |
55,015
-1,250
| -2% | -$79.5K | 0.97% | 32 |
|
|
2014
Q2 | $3.59M | Hold |
56,265
| – | – | 1.03% | 31 |
|
|
2014
Q1 | $3.46M | Sell |
56,265
-300
| -0.5% | -$17.5K | 1.07% | 32 |
|
|
2013
Q4 | $3.25M | Sell |
56,565
-253
| -0.4% | -$14.3K | 1.01% | 31 |
|
|
2013
Q3 | $3.03M | Buy |
+56,818
| New | +$3.06M | 1.05% | 29 |
|
Other funds holding MDT
VCM
VPM
First Nebraska Trust's MDT Position: Q1 2026 in Review
First Nebraska Trust reduced its Medtronic (MDT) stake by 0.18% in Q1 2026, selling an estimated $11.8K and leaving 69,352 shares worth $6.01M. The position accounts for 0.56% of the portfolio, ranked #41.
First Nebraska Trust first reported a position in MDT in Q3 2013 and has held it in 51 quarters since. The position peaked at $8.06M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- First Nebraska Trust held 69,352 shares of Medtronic worth $6.01M as of Q1 2026.
- First Nebraska Trust sold 123 Medtronic shares in Q1 2026, an estimated $11.8K.
- Medtronic made up 0.56% of First Nebraska Trust's portfolio in Q1 2026, its #41 holding.
- First Nebraska Trust first reported a position in Medtronic in Q3 2013 and has held it in 51 quarters since.
- First Nebraska Trust's Medtronic position peaked at $8.06M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.